December 22, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Giapreza (angiotensin II) to increase blood pressure in adults with septic or other distributive shock
- National Drug Code Directory (updated)
- One-Time Report on Marketing Status Required by FDARA
- Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System Guidance for Industry (PDF - 161KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario